Subscribe
Institutional subscriptions
If you are interested in how to subscribe as an institution please contact your regional sales representative, or our sales office, by registering your interest below.
Subscribe today and your institution will enjoy full access to Annals of Rheumatic Diseases (ARD) – the world’s leading journal for original Rheumatology research.
-
Online Access
- Global, high quality research from EULAR’s leading journal
- Enjoy 24/7 access on your desktop, tablet or smartphone
- Lay summaries available for non-specialist clinicians and patients
-
Print and Online
- Monthly print copy of ARD delivered to your institution
- Full access to the online journal, including Online first articles
- Access to content dating back to 1925
Personal subscriptions
Subscribe as an individual today to get full access to all new and previous content from Annals of Rheumatic Diseases (ARD) – the world’s leading journal for original Rheumatology research.
-
Best Value
Online Access
£241 per year
excluding VAT
- More than 90 years of high quality research available
- Enjoy 24/7 access on your desktop, tablet or smartphone
-
Print and Online
£431 per year
excluding VAT
- Monthly delivery of ARD print copy directly to you
- Full access to the online journal and back archive
About your subscription
Receiving your print copies
Within four weeks of placing your order you will be sent the current issue of the publication, the print journal will be delivered to the address that you provide when you register.
Renewing your subscription
Our subscriptions are annual and last for 365 days from date of purchase. This does not mean your subscription will automatically end after 365 days as you will receive a renewal notice prior to its end which will enable you to continue your subscription without interruption.
Customer Service
If you have any further queries about your subscription, please contact our customer services team on +44 (0) 207111 1105 or via email at support@bmj.com.
More about the journal
You can find out more about the Annals of Rheumatic Diseases (ARD) here.